A randomized phase III trial comparing standard and high-dose pemetrexed as second-line treatment in patients with locally advanced or metastatic non-small-cell lung cancer

Title
A randomized phase III trial comparing standard and high-dose pemetrexed as second-line treatment in patients with locally advanced or metastatic non-small-cell lung cancer
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume 19, Issue 5, Pages 939-945
Publisher
Oxford University Press (OUP)
Online
2008-02-19
DOI
10.1093/annonc/mdm592

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now